MIT's recent investment in Marksans Pharma underscores the small-cap's hidden gem status, fuelled by its strong presence in stable OTC markets and strategic growth initiatives, signalling promising prospects for revenue and profit expansion.
Related Keywords
United Kingdom , Marksans Pharma , Markans Pharma , Investment Management Company , Quant Smallcap Fund , Massachusetts Institute Of Technology , Management Company , Orbimed Asia , Tevapharm India , Abbreviated New Drug Applications ,
comparemela.com © 2020. All Rights Reserved.